BMC Infect Dis . Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain

[tetano]

BMC Infect Dis


. 2026 Feb 6.
doi: 10.1186/s12879-026-12796-8. Online ahead of print.
Use of anti-nucleocapsid antibody detection as a marker of SARS-CoV-2 infection in healthcare professionals: a longitudinal seroprevalence study at a university hospital in Catalonia, Spain

Miquel Micó ^{1 2 3} , Jaume Trapé ^{4 5 6 7} , Laura González-García ^{1 2 3} , Glòria Trujillo-Isern ^{1 2 3} , Carolina González-Fernández ^{1 2 8} , Joan López-Madueño ^{1 2} , Silvia Bérgamo ^{1 2 3} , Rafel Pérez-Vidal ⁹ , Antonia Flor ⁹ , Rosa Martínez-Montero ^{1 2} , Jose Rives ^{10 11} , Anna Arnau ^{12 13} , Anna Fàbrega ^{3 14 15} ; Althaia Serology Group


Affiliations

• PMID: 41652586
• DOI: 10.1186/s12879-026-12796-8

Free article
No abstract available